Sintx Technologies, Inc.
SINT Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$1.58
KIRA · Stoqly’s AI analyst, in plain words
- Sintx Technologies, Inc. had $1.0M of revenue in fiscal 2025, down 64.7% on the year before. Over five years, revenue changed +11.4% a year on average.
- Its operating margin was −1,053.1%, down 566.6 pts: of every 100 in sales, about −1,053 is left after running the business.
- Sintx Technologies, Inc. lost $10.4M in fiscal 2025.
- Free cash flow was −$8.8M in fiscal 2025, −860.1% of revenue.
- Sintx Technologies, Inc. returned $0.1M to shareholders in fiscal 2025. The diluted share count rose 272.4%.
- Sintx Technologies, Inc. has $4.1M more cash than debt.
Market cap
$7.7M
P/E
—
Revenue
$1.0M
Net income
−$10.4M
Free cash flow
−$8.8M
Operating margin
−1,053.1%
Sintx Technologies, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−64.7%
No. Sales fell 64.7% last year.
Does it make a profit?
−1,018.1%
No. It lost money last year.
Does profit turn into cash?
−860.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Sintx Technologies, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 20, 2026
- Legal name
- Sintx Technologies, Inc.
- CIK
- 0001269026
Sintx Technologies, Inc. · SINT
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.6M | $1.6M | $2.6M | $2.9M | $1.0M |
| Revenue growth | 2.0% | 157.6% | 68.3% | 9.9% | −64.7% |
| Gross margin | 25.9% | 83.0% | 70.2% | 71.9% | 45.3% |
| Operating margin | −1,752.5% | −726.1% | −508.5% | −486.6% | −1,053.1% |
| Net income | −$9.3M | −$12.0M | −$8.3M | −$11.0M | −$10.4M |
| Net margin | −1,536.1% | −771.2% | −314.4% | −381.8% | −1,018.1% |
| Diluted EPS | −$39.91 | −$60.81 | −$624.47 | −$15.19 | −$6.16 |
| Cash | |||||
| Cash from operations | −$10.1M | −$10.3M | −$14.1M | −$8.6M | −$8.6M |
| Capital expenditure | $3.7M | $1.4M | $0.5M | $0.7M | $0.2M |
| Free cash flow | −$13.9M | −$11.7M | −$14.6M | −$9.3M | −$8.8M |
| FCF margin | −2,288.9% | −747.5% | −557.5% | −323.2% | −860.1% |
| Share buybacks | — | — | — | — | $0.1M |
| Share count change | −98.6% | 26.6% | −93.1% | 3,316.5% | 272.4% |
| Debt and strength | |||||
| Cash and short-term investments | $14.3M | $6.2M | $3.3M | $3.6M | $4.1M |
| Debt incl. finance leases | $1.0M | $0.5M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $17.2M | $5.7M | $8.8M | $3.9M | $2.9M |
| Current ratio | 5.5x | 0.9x | 1.9x | 2.3x | 1.5x |
| Returns and quality | |||||
| Return on capital | −212.9% | — | −192.6% | −3,383.3% | — |
| Return on equity | −43.3% | −105.1% | −114.1% | −174.1% | −303.8% |
| Return on tangible equity | −54.2% | −290.4% | −94.7% | −284.3% | −687.4% |
| Piotroski F-score | 3 | 4 | 5 | 4 | 3 |
| Altman Z'' | −33.1 | −58.8 | −60.8 | −105.1 | −106.0 |
Insiders bought, 12 months
$0.3M
4 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Sintx Technologies, Inc. · SINT
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.58 a share, the company is worth $7.7M.
Source: SEC EDGAR XBRL filings (CIK 0001269026). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.